351 related articles for article (PubMed ID: 28754688)
1. TRIM65 triggers β-catenin signaling via ubiquitylation of Axin1 to promote hepatocellular carcinoma.
Yang YF; Zhang MF; Tian QH; Zhang CZ
J Cell Sci; 2017 Sep; 130(18):3108-3115. PubMed ID: 28754688
[TBL] [Abstract][Full Text] [Related]
2. TRIM31 is upregulated in hepatocellular carcinoma and promotes disease progression by inducing ubiquitination of TSC1-TSC2 complex.
Guo P; Ma X; Zhao W; Huai W; Li T; Qiu Y; Zhang Y; Han L
Oncogene; 2018 Jan; 37(4):478-488. PubMed ID: 28967907
[TBL] [Abstract][Full Text] [Related]
3. TRIM65 supports bladder urothelial carcinoma cell aggressiveness by promoting ANXA2 ubiquitination and degradation.
Wei WS; Chen X; Guo LY; Li XD; Deng MH; Yuan GJ; He LY; Li YH; Zhang ZL; Jiang LJ; Chen RX; Ma XD; Wei S; Ma NF; Liu ZW; Luo JH; Zhou FJ; Xie D
Cancer Lett; 2018 Oct; 435():10-22. PubMed ID: 30075204
[TBL] [Abstract][Full Text] [Related]
4. PDZ binding kinase, regulated by FoxM1, enhances malignant phenotype via activation of β-Catenin signaling in hepatocellular carcinoma.
Yang YF; Pan YH; Cao Y; Fu J; Yang X; Zhang MF; Tian QH
Oncotarget; 2017 Jul; 8(29):47195-47205. PubMed ID: 28525379
[TBL] [Abstract][Full Text] [Related]
5. TRIM11 promotes lymphomas by activating the β-catenin signaling and Axin1 ubiquitination degradation.
Hou Y; Ding M; Wang C; Yang X; Ye T; Yu H
Exp Cell Res; 2020 Feb; 387(2):111750. PubMed ID: 31786079
[TBL] [Abstract][Full Text] [Related]
6. The E3 ubiquitin ligase RNF146 promotes colorectal cancer by activating the Wnt/β-catenin pathway via ubiquitination of Axin1.
Shen J; Yu Z; Li N
Biochem Biophys Res Commun; 2018 Sep; 503(2):991-997. PubMed ID: 29932918
[TBL] [Abstract][Full Text] [Related]
7. MARCH1 encourages tumour progression of hepatocellular carcinoma via regulation of PI3K-AKT-β-catenin pathways.
Xie L; Dai H; Li M; Yang W; Yu G; Wang X; Wang P; Liu W; Hu X; Zhao M
J Cell Mol Med; 2019 May; 23(5):3386-3401. PubMed ID: 30793486
[TBL] [Abstract][Full Text] [Related]
8. The ubiquitin ligase TRIM25 inhibits hepatocellular carcinoma progression by targeting metastasis associated 1 protein.
Zang HL; Ren SN; Cao H; Tian XF
IUBMB Life; 2017 Oct; 69(10):795-801. PubMed ID: 28861931
[TBL] [Abstract][Full Text] [Related]
9. Secalonic Acid-F, a Novel Mycotoxin, Represses the Progression of Hepatocellular Carcinoma via MARCH1 Regulation of the PI3K/AKT/β-catenin Signaling Pathway.
Xie L; Li M; Liu D; Wang X; Wang P; Dai H; Yang W; Liu W; Hu X; Zhao M
Molecules; 2019 Jan; 24(3):. PubMed ID: 30678274
[TBL] [Abstract][Full Text] [Related]
10. TRIM32 triggers β-catenin signaling through ubiquitylation of AXIN1 to promote inflammatory factor-induced apoptosis of rat nucleus pulposus cells.
Chen F; Guo Q; Chen Q; Han Z; Zhou X; Wu L; Guo X; Ni B; Yang J
Am J Physiol Cell Physiol; 2020 Mar; 318(3):C695-C703. PubMed ID: 31967859
[TBL] [Abstract][Full Text] [Related]
11. TRIM65 knockout inhibits the development of HCC by polarization tumor-associated macrophages towards M1 phenotype via JAK1/STAT1 signaling pathway.
Jiang M; Wang D; Su N; Lou W; Chen Y; Yang H; Chen C; Xi F; Chen Y; Deng L; Tang X
Int Immunopharmacol; 2024 Feb; 128():111494. PubMed ID: 38218012
[TBL] [Abstract][Full Text] [Related]
12. UBE3C promotes proliferation and inhibits apoptosis by activating the β-catenin signaling via degradation of AXIN1 in gastric cancer.
Zhang Y; Xu J; Fu H; Wei Z; Yang D; Yan R
Carcinogenesis; 2021 Feb; 42(2):285-293. PubMed ID: 32930707
[TBL] [Abstract][Full Text] [Related]
13. AXIN deficiency in human and mouse hepatocytes induces hepatocellular carcinoma in the absence of β-catenin activation.
Abitbol S; Dahmani R; Coulouarn C; Ragazzon B; Mlecnik B; Senni N; Savall M; Bossard P; Sohier P; Drouet V; Tournier E; Dumont F; Sanson R; Calderaro J; Zucman-Rossi J; Vasseur-Cognet M; Just PA; Terris B; Perret C; Gilgenkrantz H
J Hepatol; 2018 Jun; 68(6):1203-1213. PubMed ID: 29525529
[TBL] [Abstract][Full Text] [Related]
14. TXNDC12 promotes EMT and metastasis of hepatocellular carcinoma cells via activation of β-catenin.
Yuan K; Xie K; Lan T; Xu L; Chen X; Li X; Liao M; Li J; Huang J; Zeng Y; Wu H
Cell Death Differ; 2020 Apr; 27(4):1355-1368. PubMed ID: 31570854
[TBL] [Abstract][Full Text] [Related]
15. Tankyrase inhibitors attenuate WNT/β-catenin signaling and inhibit growth of hepatocellular carcinoma cells.
Ma L; Wang X; Jia T; Wei W; Chua MS; So S
Oncotarget; 2015 Sep; 6(28):25390-401. PubMed ID: 26246473
[TBL] [Abstract][Full Text] [Related]
16. Upregulated TRIM11 Exerts its Oncogenic Effects in Hepatocellular Carcinoma Through Inhibition of P53.
Liu J; Rao J; Lou X; Zhai J; Ni Z; Wang X
Cell Physiol Biochem; 2017; 44(1):255-266. PubMed ID: 29190611
[TBL] [Abstract][Full Text] [Related]
17. NLRC5 regulates cell proliferation, migration and invasion in hepatocellular carcinoma by targeting the Wnt/β-catenin signaling pathway.
Peng YY; He YH; Chen C; Xu T; Li L; Ni MM; Meng XM; Huang C; Li J
Cancer Lett; 2016 Jun; 376(1):10-21. PubMed ID: 26975630
[TBL] [Abstract][Full Text] [Related]
18. PROX1 promotes hepatocellular carcinoma proliferation and sorafenib resistance by enhancing β-catenin expression and nuclear translocation.
Liu Y; Ye X; Zhang JB; Ouyang H; Shen Z; Wu Y; Wang W; Wu J; Tao S; Yang X; Qiao K; Zhang J; Liu J; Fu Q; Xie Y
Oncogene; 2015 Oct; 34(44):5524-35. PubMed ID: 25684142
[TBL] [Abstract][Full Text] [Related]
19. CSN5 Promotes Hepatocellular Carcinoma Progression by SCARA5 Inhibition Through Suppressing β-Catenin Ubiquitination.
Liu H; Hu J; Pan H; Luo D; Huang M; Xu W
Dig Dis Sci; 2018 Jan; 63(1):155-165. PubMed ID: 29189991
[TBL] [Abstract][Full Text] [Related]
20. Ubiquitin-like protein FAT10 promotes the invasion and metastasis of hepatocellular carcinoma by modifying β-catenin degradation.
Yuan R; Wang K; Hu J; Yan C; Li M; Yu X; Liu X; Lei J; Guo W; Wu L; Hong K; Shao J
Cancer Res; 2014 Sep; 74(18):5287-300. PubMed ID: 25056121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
